Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Critical Care Medicine · Acute Respiratory Distress Syndrome

What Is ECMO Treatment for Severe ARDS? Risks and Benefits

At a Glance

VV ECMO is temporary life support for carefully selected people with severe ARDS whose blood oxygen remains dangerously low despite optimized treatment. It acts as an artificial lung, allowing lower ventilator pressures while the underlying illness is treated and the lungs recover.

Extracorporeal Membrane Oxygenation (ECMO) is an advanced life-support machine that acts as an artificial lung for patients with severe Acute Respiratory Distress Syndrome (ARDS) [1]. In ARDS, severe inflammation and fluid build up in the lungs, making it extremely difficult for oxygen to enter the blood and carbon dioxide to leave.

When an experienced medical team determines that a mechanical ventilator cannot safely provide enough oxygen or remove enough carbon dioxide, they may consider a specific type of ECMO called Venovenous (VV) ECMO [1]. VV ECMO is an advanced support option for carefully selected patients [2]. It pumps the patient’s blood outside of their body, adds oxygen, removes carbon dioxide, and returns the oxygen-rich blood [3]. ECMO does not cure ARDS; rather, it performs the work of breathing so the patient’s own lungs have time to rest and heal while doctors treat the underlying cause, such as pneumonia or a severe infection [3].

How VV ECMO Works

In Venovenous (VV) ECMO, large tubes called cannulas are placed into large veins, typically in the neck or groin [3].

  1. The machine continuously draws dark, oxygen-poor blood out of the body and passes it through an oxygenator [3].
  2. The oxygenator acts as an artificial lung, passing oxygen into the blood and pulling carbon dioxide out [4].
  3. The now bright red, oxygen-rich blood is returned to the patient’s venous circulation [3].

Important: VV ECMO only supports the lungs; it relies on the patient’s own heart to pump the oxygenated blood to the rest of the body [3]. If a patient’s heart is also failing, a different ECMO configuration (such as VA ECMO) or other treatments might be needed.

Why is ECMO Used for ARDS?

ECMO may be considered when a patient has refractory hypoxemia—dangerously low blood oxygen levels that do not improve despite optimized medical care [1]. Before considering ECMO, doctors ensure the patient is receiving optimized ARDS care, which includes treating the underlying illness, using appropriate pressure on the ventilator (PEEP) to keep the lungs open, selectively giving medications to temporarily paralyze the muscles if needed, and turning the patient onto their stomach (proning) [1].

When these measures are not enough, ECMO offers two critical benefits:

  • Life Support: It provides the gas exchange necessary for the brain and vital organs to survive [3].
  • Lung Rest: High ventilator pressures can damage fragile, inflamed ARDS lungs. Because the ECMO machine handles gas exchange, doctors can safely lower the ventilator’s volume and pressure [5]. This “ultra-protective ventilation” helps prevent further ventilator-induced injury [6]. The patient remains on the ventilator, which provides a steady baseline pressure to keep the lungs from collapsing, but the machine does less aggressive work.

Candidacy and Timing

ECMO is typically a temporary measure, primarily used as a “bridge to recovery” to buy time for the underlying lung injury to resolve [3]. In rare cases, if the lungs cannot heal, it may be used as a bridge to a lung transplant [3].

The decision to start ECMO is highly individualized [7]. Research suggests that early consultation with an experienced ECMO center is beneficial, often within the first week of severe mechanical ventilation [8]. However, there is no single deadline, and teams must weigh the patient’s age, other organ failures, bleeding risks, and overall goals of care [7] [9]. ECMO is not appropriate for everyone, and it does not guarantee that the lungs will heal [10].

Risks and Complications

ECMO is a highly invasive therapy that carries significant, life-threatening risks:

  • Bleeding: Because blood clots when it touches the plastic tubing of the ECMO circuit, patients usually require blood thinners (anticoagulation) [9]. This increases the risk of major bleeding, including bleeding in the brain (intracranial hemorrhage), which is closely tied to mortality [11]. If a patient is actively bleeding, the team can temporarily adjust or withhold the blood thinners, carefully balancing the risks [9].
  • Blood Clots and Circuit Issues: Despite blood thinners, dangerous clots can still form in the tubes (cannula thrombosis) or the oxygenator, requiring the team to change parts of the circuit [12].
  • Hemolysis: The mechanical pumping can damage or break open red blood cells, a complication linked to worse outcomes [13].
  • Other Complications: Patients face risks of severe bloodstream infections, kidney injury, and profound weakness [9].

What to Expect in the ICU

Having a loved one on ECMO is an intense experience. The ECMO machine does not treat the underlying infection or disease; it simply buys time. During this period:

  • Monitoring: You will see continuous monitoring, frequent blood tests, and imaging to check for bleeding and lung recovery.
  • Sedation and Mobility: While patients are often heavily sedated initially, some ECMO centers gradually lighten sedation to allow the patient to wake up, interact, and even participate in physical therapy while still on the machine.
  • Uncertainty: Outcomes vary substantially depending on the cause of ARDS and the patient’s prior health. Families should have honest conversations with the care team about what recovery looks like and what the alternatives are if the lungs do not improve.

(Note: This information provides a general overview and cannot predict any one person’s outcome.)

Common questions in this guide

How does VV ECMO help someone with severe ARDS?
VV ECMO draws oxygen-poor blood through an oxygenator outside the body, adds oxygen, removes carbon dioxide, and returns the blood to a vein. The patient’s heart then pumps the oxygenated blood through the body. It supports the lungs but does not cure the underlying cause of ARDS.
When do doctors consider ECMO for severe ARDS?
Doctors may consider it when blood oxygen remains dangerously low despite optimized ARDS care, such as treating the cause, careful ventilator settings, proning, and other needed medicines. An experienced ECMO team also considers other organ problems, bleeding risk, age, prior health, and the person’s goals of care.
Does ECMO cure severe ARDS, and how long is it used?
ECMO does not cure ARDS; it temporarily performs much of the work of gas exchange while the lungs rest and clinicians treat the underlying illness. It is usually used as a bridge to recovery, although it may rarely bridge a patient to lung transplantation when the lungs do not heal.
What are the main risks of ECMO for ARDS?
ECMO can cause life-threatening bleeding because blood thinners are often needed, including bleeding in the brain. Clots in the circuit, damage to red blood cells, bloodstream infection, kidney injury, and severe weakness are other important risks.
What happens in the ICU while a patient is on ECMO?
The team continuously monitors the patient and performs frequent blood tests and imaging to look for complications and signs of lung recovery. Sedation is often used at first, but some centers gradually wake patients and provide physical therapy while ECMO continues. Ventilator settings may be lowered to reduce additional lung injury.
How do doctors decide whether ECMO can be weaned?
The team looks for evidence that the lungs are recovering, using the patient’s oxygen and carbon dioxide levels, ventilator needs, blood tests, and imaging. They may gradually reduce ECMO support to see whether the lungs can maintain safe gas exchange. The timing is individualized and does not follow a single deadline.
Does every person with severe ARDS qualify for ECMO?
No. ECMO is reserved for carefully selected patients after other treatments have been optimized, and the team weighs factors such as other organ failure, bleeding risk, overall health, and goals of care. Early discussion with an experienced ECMO center may be helpful, and transfer may be considered when local expertise is limited.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific criteria or tests will you use to determine if the underlying lung injury is beginning to heal?
  2. 2.How are you balancing the need for blood thinners with the risk of bleeding for my loved one?
  3. 3.Does our current hospital have an experienced ECMO team, or would my loved one need to be transferred to a specialized center?
  4. 4.What is the plan for 'weaning' (gradually reducing support to see if the lungs can work on their own) off the ECMO machine?
  5. 5.What would the plan of care look like if ECMO is not appropriate or if the lungs do not recover?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Extracorporeal Strategies in Acute Respiratory Distress Syndrome.

    Cavayas YA, Thakore A, Fan E

    Seminars in respiratory and critical care medicine 2019; (40(1)):114-128 doi:10.1055/s-0039-1685191.

    PMID: 31060093
  2. 2

    Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.

    Ramanathan K, Antognini D, Combes A, et al.

    The Lancet. Respiratory medicine 2020; (8(5)):518-526 doi:10.1016/S2213-2600(20)30121-1.

    PMID: 32203711
  3. 3

    Editorial on "Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the Extracorporeal Life Support Organization database".

    Persico N, Bourenne J, Roch A

    Journal of thoracic disease 2017; (9(9)):2762-2765 doi:10.21037/jtd.2017.07.98.

    PMID: 29221234
  4. 4

    Extracorporeal gas exchange: when to start and how to end?

    Gattinoni L, Vassalli F, Romitti F, et al.

    Critical care (London, England) 2019; (23(Suppl 1)):203 doi:10.1186/s13054-019-2437-2.

    PMID: 31200746
  5. 5

    Extracorporeal membrane oxygenation: beyond rescue therapy for acute respiratory distress syndrome?

    Combes A, Bréchot N, Luyt CE, Schmidt M

    Current opinion in critical care 2017; (23(1)):60-65 doi:10.1097/MCC.0000000000000375.

    PMID: 27875409
  6. 6

    Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and Practice.

    Abrams D, Schmidt M, Pham T, et al.

    American journal of respiratory and critical care medicine 2020; (201(5)):514-525 doi:10.1164/rccm.201907-1283CI.

    PMID: 31726013
  7. 7

    Nosocomial Infections During Extracorporeal Membrane Oxygenation: Incidence, Etiology, and Impact on Patients' Outcome.

    Grasselli G, Scaravilli V, Di Bella S, et al.

    Critical care medicine 2017; (45(10)):1726-1733 doi:10.1097/CCM.0000000000002652.

    PMID: 28777198
  8. 8

    Extracorporeal Membrane Oxygenation for Respiratory Failure Related to COVID-19: A Nationwide Cohort Study.

    Nesseler N, Fadel G, Mansour A, et al.

    Anesthesiology 2022; (136(5)):732-748 doi:10.1097/ALN.0000000000004168.

    PMID: 35348610
  9. 9

    Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.

    Munshi L, Walkey A, Goligher E, et al.

    The Lancet. Respiratory medicine 2019; (7(2)):163-172 doi:10.1016/S2213-2600(18)30452-1.

    PMID: 30642776
  10. 10

    Successful extracorporeal membrane oxygenation therapy as a bridge to sequential bilateral lung transplantation for a patient after severe paraquat poisoning.

    Tang X, Sun B, He H, et al.

    Clinical toxicology (Philadelphia, Pa.) 2015; (53(9)):908-13 doi:10.3109/15563650.2015.1082183.

    PMID: 26314316
  11. 11

    Timing, Outcome, and Risk Factors of Intracranial Hemorrhage in Acute Respiratory Distress Syndrome Patients During Venovenous Extracorporeal Membrane Oxygenation.

    Hunsicker O, Beck L, Krannich A, et al.

    Critical care medicine 2021; (49(2)):e120-e129 doi:10.1097/CCM.0000000000004762.

    PMID: 33323749
  12. 12

    Sudden dysfunction of veno-venous extracorporeal membrane oxygenation caused by intermittent cannula obstruction: the key role of echocardiography.

    Ruisanchez C, Sarralde JA, Gonzalez-Fernandez C, Dominguez MJ

    Intensive care medicine 2017; (43(7)):1055-1056 doi:10.1007/s00134-017-4704-5.

    PMID: 28184952
  13. 13

    Hemolysis in patients with Extracorporeal Membrane Oxygenation therapy for severe Acute Respiratory Distress Syndrome - a systematic review of the literature.

    Materne LA, Hunsicker O, Menk M, Graw JA

    International journal of medical sciences 2021; (18(8)):1730-1738 doi:10.7150/ijms.50217.

    PMID: 33746589

This page is for informational purposes only and does not constitute medical advice. It cannot predict an individual outcome; the ICU and ECMO team should explain options for your loved one.

Get notified when new evidence is published on Acute lung injury.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.